IL2RB (P14784) variants and mutations
IL2RB (also known as P14784) is a human protein-coding gene encoding an interleukin-2 receptor subunit beta protein. It transmits signals from IL-2 and IL-15 that are essential for regulatory T cells, natural-killer cells, and memory lymphocytes. Biallelic pathogenic variants can cause combined immunodeficiency with prominent autoimmunity and defective immune regulation. This analysis covers 1,084 IL2RB variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes Immunodeficiency syndrome with autoimmunity, primary cutaneous T-cell non-Hodgkin lymphoma, and multiple sclerosis. Example IL2RB variants include A2T, A2V, and A3G.
Variant analysis overview
- Gene: IL2RB
- Protein: P14784
- UniProt accession: P14784
- Organism: Homo sapiens
- Variants analyzed: 1084
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 625 unspecified-consequence records; 2 stop lost; 148 synonymous variants; 256 missense variants; 29 frameshift variants; 2 in-frame insertions; 17 stop-gained variants; 5 in-frame deletions
- Prediction scores: 932 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Immunodeficiency syndrome with autoimmunity, primary cutaneous T-cell non-Hodgkin lymphoma, multiple sclerosis, kidney transplant, renal cell carcinoma, neoplasm, neurodegenerative disease, metastatic melanoma, immune system disorder, asthma, melanoma, acute myeloid leukemia.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 4 post-translational modification sites.
- Structural context: 119 variants have structural context.
- PTM context: 4 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable IL2RB variants
Examples include A2T, A2V, A3G, A3S, A3V, P4L, P4T, A5G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD rs1471340783, REVEL 0.39, CADD 22.00
- A2V (p.Ala2Val), rs769321719, ClinGen CA10216786, ClinVar RCV001920179, ClinVar RCV005851981, REVEL 0.46, CADD 23.20, Uncertain significance, not specified; not provided
- A3G (p.Ala3Gly), gnomAD rs1440345674, REVEL 0.23, CADD 3.28
- A3S (p.Ala3Ser), TOPMed rs1922116818, REVEL 0.32, CADD 7.41
- A3V (p.Ala3Val), rs1440345674, ClinGen CA411429834, ClinVar RCV004405239, REVEL 0.34, CADD 3.85, Uncertain significance, not specified
- P4L (p.Pro4Leu), Ensembl rs542508078
- P4T (p.Pro4Thr), rs1203813846, ClinGen CA411429833, ClinVar RCV001947372, gnomAD rs1203813846, REVEL 0.26, CADD 0.39, Uncertain significance, not provided
- A5G (p.Ala5Gly), rs148235304, ClinGen CA324056665, ClinVar RCV003086352, ClinVar RCV005854416, REVEL 0.25, CADD 5.88, Uncertain significance, not specified; not provided
- A5S (p.Ala5Ser), TOPMed rs867041691, gnomAD rs867041691, REVEL 0.28, CADD 3.78
- A5T (p.Ala5Thr), TOPMed rs867041691, gnomAD rs867041691, REVEL 0.35, CADD 6.86
- A5V (p.Ala5Val), TOPMed rs148235304, gnomAD rs148235304, REVEL 0.40, CADD 16.70, Uncertain significance
- L6M (p.Leu6Met), TOPMed rs973200850, gnomAD rs973200850, REVEL 0.27, CADD 15.40
- L6V (p.Leu6Val), TOPMed rs973200850, gnomAD rs973200850, REVEL 0.28, CADD 9.39
- W8* (p.Trp8Ter), gnomAD rs1351067152, CADD 33.00, Uncertain significance
- W8C (p.Trp8Cys), rs1351067152, gnomAD rs1351067152, ClinGen CA411429806, ClinVar RCV001903329, REVEL 0.34, CADD 8.96, Uncertain significance, not provided
- R9C (p.Arg9Cys), rs143132364, ClinGen CA10216783, ClinVar RCV002005185, 1000Genomes rs143132364, REVEL 0.33, CADD 0.00, Uncertain significance, not provided
- R9H (p.Arg9His), rs147593802, ClinGen CA10216782, ClinVar RCV001935168, 1000Genomes rs147593802, REVEL 0.29, CADD 0.72, Uncertain significance, not provided
- L10V (p.Leu10Val), rs57770674, ClinGen CA10216781, ClinVar RCV001515583, UniProt VAR 061186, REVEL 0.28, CADD 23.00, Benign/Likely benign, not provided
- P11L (p.Pro11Leu), gnomAD rs1453524501, REVEL 0.40, CADD 3.04
- P11S (p.Pro11Ser), TOPMed rs796822195, gnomAD rs796822195, REVEL 0.38, CADD 0.52, Uncertain significance
- P11T (p.Pro11Thr), rs796822195, ClinGen CA324056640, ClinVar RCV002035831, ClinVar RCV004046161, REVEL 0.38, CADD 2.79, Uncertain significance, not specified; not provided
- L12F (p.Leu12Phe), ExAC rs758438266, TOPMed rs758438266, gnomAD rs758438266, REVEL 0.28, CADD 17.10, Uncertain significance, not specified
- L12P (p.Leu12Pro), Ensembl rs1922113506, REVEL 0.61, CADD 23.60
- L13F (p.Leu13Phe), TOPMed rs1402969708, gnomAD rs1402969708, REVEL 0.39, CADD 23.30
- L15P (p.Leu15Pro), gnomAD rs1471596848, REVEL 0.84, CADD 25.80
- L17P (p.Leu17Pro), ExAC rs755168776, gnomAD rs755168776, REVEL 0.69, CADD 23.70
- P18L (p.Pro18Leu), gnomAD rs1217784015, REVEL 0.42, CADD 10.40
- P18S (p.Pro18Ser), TOPMed rs1001259966, gnomAD rs1001259966, REVEL 0.32, CADD 0.09, Likely benign, not specified
- P18T (p.Pro18Thr), TOPMed rs1001259966, gnomAD rs1001259966, REVEL 0.35, CADD 0.21
- A20S (p.Ala20Ser), TOPMed rs1035282252, gnomAD rs1035282252, REVEL 0.39, CADD 12.80, Uncertain significance
- A20T (p.Ala20Thr), rs1035282252, ClinGen CA324056613, ClinVar RCV001961501, TOPMed rs1035282252, REVEL 0.27, CADD 6.71, Uncertain significance, not provided
- A20V (p.Ala20Val), rs538970680, ClinGen CA10216776, ClinVar RCV001907831, 1000Genomes rs538970680, REVEL 0.39, CADD 9.10, Uncertain significance, not provided
- T21I (p.Thr21Ile), gnomAD rs1207895510, REVEL 0.40, CADD 0.60
- S22F (p.Ser22Phe), gnomAD rs1247021813
- S22P (p.Ser22Pro), rs145316401, ClinGen CA10216775, ClinVar RCV002027140, 1000Genomes rs145316401, REVEL 0.42, CADD 0.01, Uncertain significance, not provided
- W23* (p.Trp23Ter), TOPMed rs1161591877, gnomAD rs1161591877, CADD 34.00
- A24E (p.Ala24Glu), gnomAD rs1364479542, REVEL 0.39, CADD 3.33
- A24S (p.Ala24Ser), NCI-TCGA TCGA novel, REVEL 0.36, CADD 2.84, Variant assessed as somatic; moderate impact.
- A24V (p.Ala24Val), gnomAD rs1364479542, REVEL 0.24, CADD 0.14
- S25F (p.Ser25Phe), gnomAD rs6000577
- S25Y (p.Ser25Tyr), gnomAD rs6000577, REVEL 0.35, CADD 21.40
- A26V (p.Ala26Val), ExAC rs761189356, gnomAD rs761189356, REVEL 0.29, CADD 12.90
- A27T (p.Ala27Thr), TOPMed rs1403989214, gnomAD rs1403989214, REVEL 0.31, CADD 13.70, Uncertain significance, not provided
- A27V (p.Ala27Val), rs141522549, ClinGen CA10216773, ClinVar RCV003548048, ESP rs141522549, REVEL 0.23, CADD 1.68, Uncertain significance, not provided
- V28L (p.Val28Leu), Ensembl rs1922108850, REVEL 0.24, CADD 4.38
- G30S (p.Gly30Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T31A (p.Thr31Ala), TOPMed rs1922074676
- T31I (p.Thr31Ile), TOPMed rs1427722386, gnomAD rs1427722386, REVEL 0.28, CADD 10.30
- S32F (p.Ser32Phe), TOPMed rs1922074196
- Q33* (p.Gln33Ter), rs2517845076, ClinGen CA411429657, ClinVar RCV003670293, CADD 33.00, Pathogenic
- Q33R (p.Gln33Arg), rs147889445, ClinGen CA10216745, ClinVar RCV002044117, ESP rs147889445, REVEL 0.28, CADD 1.85, Uncertain significance, not provided
- F34L (p.Phe34Leu), gnomAD rs1442503379, REVEL 0.12, CADD 13.40
- T35S (p.Thr35Ser), TOPMed rs1922073765, gnomAD rs1922073765, REVEL 0.13, CADD 5.04
- C36R (p.Cys36Arg), gnomAD rs1334203793, REVEL 0.76, CADD 28.10
- Y38F (p.Tyr38Phe), ExAC rs774508915, TOPMed rs774508915, gnomAD rs774508915, REVEL 0.40, CADD 25.90, Uncertain significance, not provided
- N39K (p.Asn39Lys), gnomAD rs1158099571, REVEL 0.26, CADD 23.70
- N39S (p.Asn39Ser), rs2146244957, ClinGen CA411429612, ClinVar RCV002014683, Ensembl rs2146244957, REVEL 0.30, CADD 25.10, Uncertain significance, not provided
- S40L (p.Ser40Leu), rs1922072844, ClinGen CA411429602, ClinVar RCV000787341, Ensembl rs1922072844, REVEL 0.66, CADD 28.60, Pathogenic
- R41K (p.Arg41Lys), TOPMed rs1922072432
- A42T (p.Ala42Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A42V (p.Ala42Val), gnomAD rs1409913915, REVEL 0.35, CADD 26.60
- N43S (p.Asn43Ser), ExAC rs756309404, TOPMed rs756309404, gnomAD rs756309404, REVEL 0.35, CADD 25.00
- S45C (p.Ser45Cys), NCI-TCGA Cosmic COSV5342, Variant assessed as somatic; moderate impact.
- C46G (p.Cys46Gly), NCI-TCGA Cosmic COSV5342, Variant assessed as somatic; moderate impact.
- V47D (p.Val47Asp), gnomAD rs1463023447, REVEL 0.54, CADD 5.40
- V47I (p.Val47Ile), ExAC rs746287644, TOPMed rs746287644, gnomAD rs746287644, REVEL 0.19, CADD 1.95, Uncertain significance
- V47L (p.Val47Leu), rs746287644, ClinGen CA10216738, ClinVar RCV001957725, ExAC rs746287644, REVEL 0.26, CADD 2.64, Uncertain significance, not provided
- S49N (p.Ser49Asn), ExAC rs781374102, TOPMed rs781374102, gnomAD rs781374102, REVEL 0.28, CADD 12.30
- Q50* (p.Gln50Ter), gnomAD rs1315445230, CADD 35.00
- Q50E (p.Gln50Glu), NCI-TCGA Cosmic COSV9934, Variant assessed as somatic; moderate impact.
- Q50P (p.Gln50Pro), ExAC rs757808344, gnomAD rs757808344, REVEL 0.48, CADD 0.15
- D51N (p.Asp51Asn), TOPMed rs1922070245, gnomAD rs1922070245, REVEL 0.16, CADD 11.20, Uncertain significance, not specified
- G52A (p.Gly52Ala), ExAC rs764846722, TOPMed rs764846722, gnomAD rs764846722, REVEL 0.19, CADD 1.59
- G52E (p.Gly52Glu), ExAC rs764846722, TOPMed rs764846722, gnomAD rs764846722, REVEL 0.38, CADD 0.39
- G52R (p.Gly52Arg), TOPMed rs1378071597, gnomAD rs1378071597, REVEL 0.19, CADD 11.00, Uncertain significance, not specified
- G52V (p.Gly52Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A53G (p.Ala53Gly), rs2146244862, ClinGen CA411429516, ClinVar RCV001977778, Ensembl rs2146244862, REVEL 0.19, CADD 0.10, Uncertain significance, not provided
- Q55K (p.Gln55Lys), rs538933768, ClinGen CA10216733, ClinVar RCV002090618, 1000Genomes rs538933768, REVEL 0.26, CADD 8.29, Likely benign, not provided
- Q55P (p.Gln55Pro), TOPMed rs1016769370, gnomAD rs1016769370, REVEL 0.53, CADD 4.41
- Q55R (p.Gln55Arg), TOPMed rs1016769370, gnomAD rs1016769370, REVEL 0.25, CADD 4.07
- S58Y (p.Ser58Tyr), TOPMed rs1922069074, REVEL 0.51, CADD 21.90
- H62R (p.His62Arg), Ensembl rs2146244826
- H62Y (p.His62Tyr), rs185863845, ClinGen CA10216731, ClinVar RCV002301408, 1000Genomes rs185863845, REVEL 0.33, CADD 4.51, Uncertain significance, not provided
- A63P (p.Ala63Pro), TOPMed rs1922068109
- W64* (p.Trp64Ter), NCI-TCGA Cosmic COSV9934, Variant assessed as somatic; high impact.
- P65L (p.Pro65Leu), rs371340355, ClinGen CA10216729, ClinVar RCV001332608, ClinVar RCV002546583, REVEL 0.34, CADD 20.40, Uncertain significance, not provided; Immunodeficiency 63 with lymphoproliferation and autoimmunity
- P65R (p.Pro65Arg), ESP rs371340355, ExAC rs371340355, TOPMed rs371340355, gnomAD rs371340355, REVEL 0.32, CADD 21.40, Uncertain significance
- P65S (p.Pro65Ser), rs2517844926, ClinGen CA411429438, ClinVar RCV003665244, Uncertain significance, not provided
- R68Q (p.Arg68Gln), gnomAD rs1182012759, REVEL 0.63, CADD 33.00
- R68W (p.Arg68Trp), rs375594279, ClinGen CA10216726, ClinVar RCV002043887, ESP rs375594279, REVEL 0.54, CADD 23.40, Uncertain significance, not provided
- R69G (p.Arg69Gly), 1000Genomes rs117728347, ExAC rs117728347, TOPMed rs117728347, gnomAD rs117728347, REVEL 0.34, CADD 5.17, Uncertain significance
- R69Q (p.Arg69Gln), rs992633708, ClinGen CA324055191, ClinVar RCV002004773, ClinVar RCV004043947, REVEL 0.30, CADD 0.13, Uncertain significance, not provided; not specified
- R69W (p.Arg69Trp), rs117728347, ClinGen CA10216691, NCI-TCGA Cosmic COSV5342, ClinVar RCV002582477, REVEL 0.38, CADD 12.00, Uncertain significance, not provided
- W70* (p.Trp70Ter), NCI-TCGA Cosmic COSV5342, Variant assessed as somatic; high impact.
- N71H (p.Asn71His), gnomAD rs1922017838, REVEL 0.08, CADD 18.60, Uncertain significance, not provided
- N71K (p.Asn71Lys), gnomAD rs1384696048
- Q72* (p.Gln72Ter), NCI-TCGA Cosmic COSV9934, Variant assessed as somatic; high impact.
- Q72H (p.Gln72His), ExAC rs751391631, gnomAD rs751391631, REVEL 0.32, CADD 6.30
- Q72K (p.Gln72Lys), ExAC rs756906160, gnomAD rs756906160, REVEL 0.30, CADD 0.10
- E75D (p.Glu75Asp), rs113714217, ClinGen CA324055134, ClinVar RCV002700332, ClinVar RCV004066913, REVEL 0.26, CADD 0.01, Uncertain significance, not provided; not specified
- E75Q (p.Glu75Gln), ExAC rs763830083, TOPMed rs763830083, gnomAD rs763830083, REVEL 0.28, CADD 0.37
- L77F (p.Leu77Phe), TOPMed rs1922016635, REVEL 0.32, CADD 1.58
- L77P (p.Leu77Pro), rs934523851, ClinGen CA324055131, ClinVar RCV000787340, UniProt VAR 083103, REVEL 0.45, CADD 15.10, Pathogenic, in IMD63
- P78L (p.Pro78Leu), ExAC rs762894023, gnomAD rs762894023, REVEL 0.12, CADD 0.17
- V79M (p.Val79Met), rs149508414, ClinGen CA10216684, ClinVar RCV000892425, ClinVar RCV003920782, REVEL 0.09, CADD 7.11, Benign/Likely benign, not specified; not provided
- S80N (p.Ser80Asn), TOPMed rs998550615, gnomAD rs998550615, REVEL 0.02, CADD 0.08
- Q81P (p.Gln81Pro), gnomAD rs1922015492, REVEL 0.13, CADD 0.07
- A82S (p.Ala82Ser), TOPMed rs1206721392, gnomAD rs1206721392, REVEL 0.32, CADD 0.27
- S83F (p.Ser83Phe), rs2228143, ClinGen CA10216683, ClinVar RCV000962770, ClinVar RCV003916094, REVEL 0.40, CADD 19.50, Benign, not specified; not provided
- W84R (p.Trp84Arg), TOPMed rs1922014701
- A85D (p.Ala85Asp), TOPMed rs1245550116, gnomAD rs1245550116, REVEL 0.54, CADD 19.70
- A85T (p.Ala85Thr), NCI-TCGA Cosmic COSV5342, Ensembl rs1922014550, Variant assessed as somatic; moderate impact.
- C86F (p.Cys86Phe), NCI-TCGA TCGA novel, REVEL 0.45, CADD 22.30, Variant assessed as somatic; moderate impact.
- N87K (p.Asn87Lys), TOPMed rs1922014059, gnomAD rs1922014059, REVEL 0.33, CADD 20.30
- I89F (p.Ile89Phe), 1000Genomes rs776750362, ExAC rs776750362, gnomAD rs776750362, REVEL 0.10, CADD 15.20
- L90I (p.Leu90Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G91R (p.Gly91Arg), rs773733100, ClinGen CA10216679, ClinVar RCV003682248, ExAC rs773733100, REVEL 0.33, CADD 24.10, Uncertain significance, not provided
- A92D (p.Ala92Asp), 1000Genomes rs183884204
- P93A (p.Pro93Ala), TOPMed rs1179384634
- P93S (p.Pro93Ser), TOPMed rs1179384634
- D94G (p.Asp94Gly), TOPMed rs759693142, gnomAD rs759693142, REVEL 0.10, CADD 22.90
- D94Y (p.Asp94Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S95A (p.Ser95Ala), Ensembl rs2146239252
- S95P (p.Ser95Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q96* (p.Gln96Ter), rs1569044747, ClinGen CA411428742, ClinVar RCV000709690, Ensembl rs1569044747, Pathogenic
- K97I (p.Lys97Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K97T (p.Lys97Thr), TOPMed rs1489912640, gnomAD rs1489912640
- V104I (p.Val104Ile), rs892258127, ClinGen CA324052115, ClinVar RCV002596323, TOPMed rs892258127, REVEL 0.03, CADD 0.02, Uncertain significance, not provided
- V108L (p.Val108Leu), Ensembl rs1921846931
- C110R (p.Cys110Arg), ExAC rs758258445, gnomAD rs758258445, REVEL 0.53, CADD 24.50
- C110S (p.Cys110Ser), gnomAD rs1245560280, REVEL 0.50, CADD 23.80
- R111C (p.Arg111Cys), ESP rs369774326, ExAC rs369774326, TOPMed rs369774326, gnomAD rs369774326, REVEL 0.50, CADD 18.00
- R111H (p.Arg111His), rs137877148, ClinGen CA10216666, ClinVar RCV002003740, ClinVar RCV004045205, REVEL 0.34, CADD 0.00, Uncertain significance, not specified; not provided
- G113R (p.Gly113Arg), gnomAD rs1921845370, REVEL 0.18, CADD 19.20
- V114L (p.Val114Leu), gnomAD rs899572180, REVEL 0.26, CADD 0.92
- R115* (p.Arg115Ter), gnomAD rs1283014725, CADD 30.00
- R115Q (p.Arg115Gln), rs375543770, ClinGen CA10216664, ClinVar RCV003086642, ClinVar RCV005587331, REVEL 0.03, CADD 0.01, Uncertain significance, not specified; not provided
- W116* (p.Trp116Ter), ExAC rs760990294, TOPMed rs760990294, gnomAD rs760990294, CADD 34.00
- W116C (p.Trp116Cys), ExAC rs773498163, TOPMed rs773498163, gnomAD rs773498163, REVEL 0.29, CADD 23.10
- W116R (p.Trp116Arg), ExAC rs766430737, gnomAD rs766430737, REVEL 0.11, CADD 7.27
- W116Y (p.Trp116Tyr), rs2146239158, ClinGen CA2573158131, ClinVar RCV002103994, Ensembl rs2146239158, Likely benign, not provided
- R117K (p.Arg117Lys), TOPMed rs1414118090, gnomAD rs1414118090, REVEL 0.34, CADD 7.32
- V118L (p.Val118Leu), ExAC rs767844744, gnomAD rs767844744, REVEL 0.29, CADD 0.00
- M119I (p.Met119Ile), Ensembl rs1921843414
- M119T (p.Met119Thr), rs550638824, ClinGen CA10216659, ClinVar RCV001305747, ClinVar RCV005851798, REVEL 0.32, CADD 12.80, Uncertain significance, not specified; not provided
- A120T (p.Ala120Thr), TOPMed rs865847276, gnomAD rs865847276, REVEL 0.25, CADD 0.10
- A120V (p.Ala120Val), Ensembl rs1569044679
- I121F (p.Ile121Phe), rs1405317424, ClinGen CA411428589, ClinVar RCV003064121, AlphaMissense 0.09, MetaLR 0.65, Uncertain significance, not provided
- I121M (p.Ile121Met), 1000Genomes rs532503786, ExAC rs532503786, gnomAD rs532503786, REVEL 0.33, CADD 12.40
- I121V (p.Ile121Val), rs1405317424, ClinGen CA411428590, ClinVar RCV002001109, TOPMed rs1405317424, REVEL 0.26, AlphaMissense 0.09, Uncertain significance, not provided
- Q122* (p.Gln122Ter), TOPMed rs1921842523
- Q122R (p.Gln122Arg), ExAC rs769078456, gnomAD rs769078456, REVEL 0.34, CADD 9.22
- D123E (p.Asp123Glu), ExAC rs770365586, TOPMed rs770365586, gnomAD rs770365586, REVEL 0.28, CADD 0.94, Uncertain significance, not provided
- D123G (p.Asp123Gly), gnomAD rs1921841661, REVEL 0.46, CADD 7.81
- D123H (p.Asp123His), ExAC rs776022568, gnomAD rs776022568, REVEL 0.44, CADD 8.28
- D123N (p.Asp123Asn), ExAC rs776022568, gnomAD rs776022568, REVEL 0.23, CADD 0.10, Uncertain significance, not provided
- F124L (p.Phe124Leu), TOPMed rs1321097046, gnomAD rs1321097046, REVEL 0.10, CADD 21.80
- K125N (p.Lys125Asn), rs2146239071, ClinGen CA411428559, ClinVar RCV001888492, Ensembl rs2146239071, AlphaMissense 0.73, MetaLR 0.77, Uncertain significance, not provided
- F127L (p.Phe127Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L130F (p.Leu130Phe), rs146185118, NCI-TCGA Cosmic COSV9934, ESP rs146185118, ExAC rs146185118, REVEL 0.69, CADD 22.80, Uncertain significance
- L130I (p.Leu130Ile), rs146185118, ClinGen CA10216652, ClinVar RCV002770604, ESP rs146185118, REVEL 0.28, CADD 13.10, Uncertain significance, not provided
- R131C (p.Arg131Cys), rs781374953, ClinGen CA10216624, ClinVar RCV002606956, ExAC rs781374953, REVEL 0.84, CADD 32.00, Uncertain significance, not provided
- R131H (p.Arg131His), NCI-TCGA Cosmic COSV5342, TOPMed rs1160622087, gnomAD rs1160622087, REVEL 0.72, CADD 27.10, Variant assessed as somatic; moderate impact.
- R131L (p.Arg131Leu), rs1160622087, NCI-TCGA Cosmic COSV5342, TOPMed rs1160622087, gnomAD rs1160622087, REVEL 0.75, CADD 25.60, Variant assessed as somatic; moderate impact.
- L132P (p.Leu132Pro), TOPMed rs1221462854, gnomAD rs1221462854, REVEL 0.73, CADD 26.50
- M133I (p.Met133Ile), Ensembl rs1921777451
- M133T (p.Met133Thr), Ensembl rs1921777604
- A134T (p.Ala134Thr), Ensembl rs1601599248
- A134V (p.Ala134Val), 1000Genomes rs201441730, ExAC rs201441730, TOPMed rs201441730, gnomAD rs201441730, REVEL 0.60, CADD 25.10, Uncertain significance, not specified
- I136F (p.Ile136Phe), ExAC rs764222346, TOPMed rs764222346, gnomAD rs764222346, REVEL 0.41, CADD 1.27, Uncertain significance
- I136L (p.Ile136Leu), rs764222346, ClinGen CA10216621, ClinVar RCV001903930, ClinVar RCV005584959, REVEL 0.23, CADD 0.34, Uncertain significance, not provided; not specified
- I136V (p.Ile136Val), rs764222346, ClinGen CA411428432, ClinVar RCV001899594, ClinVar RCV005851952, REVEL 0.20, CADD 0.03, Uncertain significance, not specified; not provided
- S137C (p.Ser137Cys), TOPMed rs1257429954, gnomAD rs1257429954, REVEL 0.38, CADD 22.70, Uncertain significance, not specified
- V140I (p.Val140Ile), TOPMed rs1921775849, gnomAD rs1921775849, REVEL 0.30, CADD 7.89
- V143L (p.Val143Leu), ExAC rs752982148, gnomAD rs752982148, REVEL 0.28, CADD 0.01, Uncertain significance
- V143M (p.Val143Met), ExAC rs752982148, gnomAD rs752982148, REVEL 0.39, CADD 0.03, Uncertain significance, not provided; not specified
- T145I (p.Thr145Ile), gnomAD rs1216875084, REVEL 0.18, CADD 19.60
- H146R (p.His146Arg), TOPMed rs1244275084, gnomAD rs1244275084, REVEL 0.20, CADD 3.00
- C148Y (p.Cys148Tyr), Ensembl rs1921774867, REVEL 0.37, CADD 20.90
- N149S (p.Asn149Ser), ExAC rs765775857, gnomAD rs765775857, REVEL 0.63, CADD 24.50
Public IL2RB analysis runs
- IL2RB analysis run — IL2RB (1,084 variants) — completed 2026-08-20